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em mulheres na pré e pós-menopausa
ABSTRACT
OBJECTIVE: To estimate the prevalence and analyze risk factors associated 
to osteoporosis and low-trauma fracture in women.
METHODS: Cross-sectional study including a total of 4,332 women older 
than 40 attending primary care services in the Greater São Paulo, Southeastern 
Brazil, between 2004 and 2007. Anthropometrical and gynecological data and 
information about lifestyle habits, previous fracture, medical history, food 
intake and physical activity were obtained through individual quantitative 
interviews. Low-trauma fracture was defi ned as that resulting from a fall 
from standing height or less in individuals 50 years or older. Multiple logistic 
regression models were designed having osteoporotic fracture and bone mineral 
density (BMD) as the dependent variables and all other parameters as the 
independent ones. The signifi cance level was set at p<0.05.
RESULTS: The prevalence of osteoporosis and osteoporotic fractures was 33% 
and 11.5%, respectively. The main risk factors associated with low bone mass 
were age (OR=1.07; 95% CI: 1.06;1.08), time since menopause (OR=2.16; 
95% CI: 1.49;3.14), previous fracture (OR=2.62; 95% CI: 2.08;3.29) and 
current smoking (OR=1.45; 95% CI: 1.13;1.85). BMI (OR=0.88; 95% CI: 
0.86;0.89), regular physical activity (OR=0.78; 95% CI: 0.65;0.94) and 
hormone replacement therapy (OR=0.43; 95% CI: 0.33;0.56) had a protective 
effect on bone mass. Risk factors signifi cantly associated with osteoporotic 
fractures were age (OR=1.05; 95% CI: 1.04;1.06), time since menopause 
(OR=4.12; 95% CI: 1.79;9.48), familial history of hip fracture (OR=3.59; 95% 
CI: 2.88;4.47) and low BMD (OR=2.28; 95% CI: 1.85;2.82).
CONCLUSIONS: Advanced age, menopause, low-trauma fracture and current 
smoking are major risk factors associated with low BMD and osteoporotic 
fracture. The clinical use of these parameters to identify women at higher 
risk for fractures might be a reasonable strategy to improve the management 
of osteoporosis.
DESCRIPTORS: Fractures, Bone. Bone Density. Osteoporosis, 
Postmenopausal, epidemiology. Osteoporosis, epidemiology. Risk 
Factors. Cross-Sectional Studies. Women’s Health.
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Osteoporotic fracture is an important public health 
problem worldwide. However, its impact varies 
considerably between countries, especially due to 
population differences and different use of public health 
resources.16,21 The prevalence of osteoporotic fracture 
increases with age and is associated with a deteriorated 
quality of life as well as greater mortality rate.11 Studies 
carried out in Brazil have found that the annual (age-
adjusted) incidence of hip fracture ranges between 5.59 
to 13/10,000 inhabitants and 12.4 to 27.7/10,000 inhab-
itants in men and women, respectively.5,29,15 Clark et al6 
found a prevalence of 11.18 morphometric vertebral 
fractures in a population sample of 1,922 postmeno-
pausal women from fi ve countries of Latin America, 
RESUMO
OBJETIVO: Estimar a prevalência e analisar os fatores de risco associados 
com osteoporose e fratura por baixo impacto entre mulheres.
MÉTODOS: Estudo transversal realizado com 4.332 mulheres acima 
de 40 anos de idade provenientes de atendimento primário de saúde na 
área metropolitana da Grande São Paulo, SP, entre 2004 e 2007. Dados 
antropométricos e ginecológicos e relativos a hábitos de vida, fratura prévia, 
antecedentes pessoais, ingestão alimentar e atividade física foram avaliados 
por meio de entrevista individual e quantitativa. Fratura por baixo impacto foi 
defi nida como decorrente de queda da própria altura ou menos em indivíduos 
com mais de 50 anos de idade. Modelos de regressão multivariada e logística 
analisaram, respectivamente, a densidade óssea e a fratura por osteoporose 
como variáveis dependentes e todas as outras como independentes. O nível 
de signifi cância estatística estabelecido foi p < 0,05.
RESULTADOS: A prevalência de osteoporose e de fraturas por fragilidade 
óssea foi de 33% e 11,5%, respectivamente. Os principais fatores de risco 
associados com baixa densidade óssea foram idade (OR = 1,07; IC 95%: 
1,06;1,08), menopausa (OR = 2,16; IC 95%: 1,49;3,14), fratura prévia (OR = 
2,62; IC 95%: 2,08;3,29) e tabagismo atual (OR = 1,45; IC 95%: 1,13;1,85). 
Por outro lado, elevado IMC (OR = 0,88; IC 95%: 0,86;0,89), atividade 
física regular (OR = 0,78; IC 95%: 0,65;0,94) e terapia hormonal atual (OR = 
0,43; IC 95%: 0,33;0,56) desempenharam papel protetor. Os fatores de risco 
signifi cativamente relacionados com fratura por osteoporose foram idade 
(OR = 1,05; IC 95%: 1,04;1,06), menopausa (OR = 4,12; IC 95%: 1,79;9,48), 
história familiar de fratura de quadril (OR = 3,59; IC 95%: 2,88;4,47) e baixa 
densidade óssea (OR = 2,28; IC 95%: 1,85;2,82). 
CONCLUSÕES: Idade avançada, menopausa, fratura prévia por baixo impacto 
e tabagismo atual são os principais fatores de risco associados com baixa 
densidade óssea, a qual se associa com as fraturas por fragilidade óssea. O 
uso clínico desses parâmetros para identifi car mulheres de maior risco para 
fraturas pode ser uma estratégia interessante para melhorar a abordagem da 
osteoporose.
DESCRITORES: Fraturas Ósseas. Densidade Óssea. Osteoporose Pós-
Menopausa, epidemiologia. Osteoporose, epidemiologia. Fatores de 
Risco. Estudos Transversais. Saúde da Mulher.
INTRODUCTION
of whom 415 patients (randomly stratifi ed according 
to age) lived in the city of Vitória, Southeastern Brazil 
(95% CI: 9.23;13.4).
A number of strategies are available for the prevention 
and treatment of osteoporosis, offering an effective 
reduction in both vertebral and non-vertebral fractures. 
However, the best strategy for stratifying individuals at 
greater risk and selecting those that would most benefi t 
from therapy or prevention remains a challenge for 
physicians.1 In routine medical practice, it is used a 
combination of clinical risk factors2,4,8,30 together with 
the determination of bone mineral density (BMD).19,20 
Based on this approach, Kanis et al13 have recently 
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proposed the use of FRAXTM as a useful, objective 
tool for assessing the risk of fracture in the next ten 
years, with direct implications for decision making 
and treatment costs. However, calculating the absolute 
risk of fracture depends on the population studied and 
this tool has not yet been approved for use in Brazil, 
as there is no reference database.25 Therefore, further 
representative epidemiological data on the Brazilian 
population are needed.
The São Paulo Osteoporosis Study (SAPOS) is one 
of the most important studies on risk factors for low-
trauma fracture and osteoporosis ever carried out in 
Brazil. It studied a large sample of women, including 
premenopause and postmenopause, from different areas 
of the Greater São Paulo attending primary care services 
rather than focusing on those receiving tertiary care or 
targeting high-risk populations.
The objective of the present study was to estimate the 
prevalence of and analyze factors associated to osteo-
porosis and low-trauma fracture among women.
METHODS
A cross-sectional study was conducted. More than 
7,000 women over 40 years of age were recruited from 
primary care units in the metropolitan area of São Paulo, 
Southeastern Brazil, from January 2004 to December 
2007. Almost 62% of the initial sample (N = 4,332) met 
the eligibility criteria and were included in the study. 
A little more than half (55%) were recruited from a 
primary care unit in the city of São Caetano do Sul and 
the rest (45%) were recruited from the metropolitan 
area of São Paulo.
All participants answered a questionnaire. The study 
questionnaire was developed based on a literature 
review on different clinical risk factors related to low 
BMD and fractures,2,4,8,30 which included details about 
demographic and anthropometrical data; gynecological 
and hormonal information; personal medical history 
based on the International Classifi cation of Diseases 
(10th edition); previous fractures; family history of 
femur fracture after 50 years of age in fi rst-degree 
relatives; and current lifestyle habits (smoking, regular 
physical activity in the previous 12 months and regular 
intake of dairy products).
Regular physical activity was defi ned as any physical 
activity performed for more than 30 min and during 
three or more times per week, excluding routine activi-
ties of daily living.22 Low-trauma fracture was defi ned 
as caused by a fall from one’s own height or lower after 
50 years of age.24 The categorization of daily intake of 
dairy products was based on a frequency distribution 
of 200 mL (no serving, up to three servings, and three 
servings or more).22 The use of calcium supplements 
and vitamin D was also recorded.
Only individuals with cancer or cognitive impairment, 
such as neurological conditions or senile dementia, 
who were not able to provide adequate responses, were 
excluded from the study. The use of concomitant medi-
cations, including those related to mineral and bone 
metabolism, such as glucocorticosteroids, bisphospho-
nates, diuretics, selective estrogen receptor modulators 
and anticonvulsants, was not an exclusion criterion and 
these individuals were stratifi ed and included in the 
statistical analysis.
The interview was performed by health professionals 
at primary care units after receiving specifi c training 
from a rheumatologist with ample experience with this 
type of methodology.
Spine and femur bone densitometry (DPX NT, 
GE-Lunar) was performed in all women, using 
the acquisition and analysis protocol proposed by 
the International Society of Clinical Densitometry, 
recently validated by the Brazilian Society of Clinical 
Densitometry.3 The reference database and osteoporosis 
classifi cation criteria used were from the Third National 
Health and Nutrition Examination Survey17 and World 
Health Organization,12 respectively.
Descriptive analysis was carried out and data were 
expressed as percents (%), means and standard devia-
tions. The chi-square test was used to estimate the 
individual effect of each variable studied, with BMD 
as the dependent variable. In a complementary analysis, 
low-trauma fracture after 50 years of age was also used 
as a dependent variable in the logistic regression model. 
The routine procedure was adopted for the multivariate 
regression for which BMD was considered as dependent 
variable in each fi nal model. All p-values lower than 
0.05 were considered statistically signifi cant. Statistical 
analysis was performed by the SPSS, version 12.
All participants signed a written informed consent 
form prior to their participation in the study and 
the Research Ethics Committee of the Universidade 
Federal de São Paulo/Escola Paulista de Medicina 
approved the protocol.
RESULTS
Table 1 displays patient age and anthropometrical 
data according to the presence of low-trauma fracture. 
Women with previous osteoporotic fracture were older 
and thinner than those with no history of fracture. The 
majority of participants were Caucasians (75.2%) and 
the rest was classifi ed as non-Caucasians (24.8%), of 
whom 17.1% were mixed, 6.9% were of African descent 
and 0.8% was of Asian descent. The vast majority of 
the sample (90.9%) was in menopause, but only 444 
women (10.2%) used regular hormonal replacement 
therapy in the 12 months prior to the interview, with 
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an average duration of nearly four years. Hysterectomy 
and oophorectomy prior to menopause were reported in 
18.3% and 10.4% of the women studied, respectively.
Regular physical activity and current smoking habits 
were reported in 27.3% and 8.7% of the sample, respec-
tively. Current use of calcium supplements was reported 
in 618 women (14.3%), with an average duration of a 
little more than two years. Current regular intake of 
dairy products was reported in 78%; 63.9% of whom 
reported low daily intake (up to two servings – equiva-
lent to 500 mg of calcium) and only 14.1% reported 
adequate daily intake (more than three servings – more 
than 800 mg of calcium).
Associated diseases were reported in 2,382 women 
(55%), whereas 45% reported no health conditions. 
Diseases of the circulatory system were reported in 
1,586 women (66.6%), of which arterial hyperten-
sion was the most frequent (63.4%). A total of 963 
women (40.4%) reported having musculoskeletal-
joint disease, such as fibromyalgia (14.6%), osteoar-
thritis (12.2%) and osteoporosis (10.3%). A total of 
876 women (36.8%) reported endocrine, nutritional 
and metabolic diseases, the most prevalent of which 
were dyslipidemia (13.1%), diabetes mellitus 
(12.5%) and thyroid diseases (9.2%). Digestive tract 
conditions were reported in 54.6% of the sample, 
mostly dyspeptic symptoms. However, chronic diar-
rhea was only reported in 5% of the sample.
Nearly 90% of the sample was using some concomitant 
medication. Regular use of anti-hypertensive medica-
tion was reported in over 50% of the women, especially 
angiotensin-converting enzyme inhibitors (39.3%), 
thiazide diuretics (29.7%), beta-blockers (13.2%) 
and calcium channel blockers (3.4%). The use of oral 
biphosphonates and glucocorticosteroids was reported 
in 8% and 4% of the women, respectively. Statins and 
thyroid hormone replacement therapy were reported 
in 11.2% and 11.5% of the women, respectively. 
Approximately 10% of the women chronically used 
non-steroid anti-infl ammatory agents (9.4%) and oral 
anti-diabetic agents (9.7%).
A total of 497 women (11.5%) reported a history of 
low-trauma fracture, with a mean age of 65.5 (SD= 
10) years at the time of the event. Vertebral fractures 
were reported in 44 women (6%) and non-vertebral 
fractures were reported in 616 (86%), which included 
the humerus, distal forearm (Colles), metacarpal, ribs 
and hip. Femur fracture was reported in 55 women (8%). 
Family history of hip fracture after 50 years of age in 
fi rst-degree relatives was reported in 15% of the women, 
especially those with a previous fracture (p<0.001).
Just over 33% of the postmenopausal women had 
osteoporosis in the lumbar spine or femur, based 
on World Health Organization criteria17 (Table 2). 
Radiographic analysis revealed structural abnormali-
ties in the lumbar spine in 8% of the tests. In these 
cases, the affected vertebra was excluded from the 
analysis. Table 3 displays the characteristics of bone 
mass measurements according with the presence or 
absence of fracture. Women with a history of low-
trauma fractures had signifi cantly lower BMD in all 
the skeletal sites studied.
The fi nal multivariate regression model showed that 
the main risk factors signifi cantly associated with low 
BMD in the lumbar spine or femur were advanced age, 
menopause and current smoking habits. In contrast, 










Age (years) 59.4 (9.9) 65.5 (10.0) < 0.001
Weight (kg) 66.4 (13.3) 64.5 (11.6) 0.013
Height (m) 1.54 (0.06) 1.53 (0.06) < 0.001
Body mass index (kg/m²) 27.8 (5.2) 27.5 (4.9) 0.521
Table 2. Prevalence of osteopenia and osteoporosis in postmenopausal women according to bone mineral density and WHO 








Lumbar spine 1579 (36.4) 1674 (38.6) 1079 (24.9)
Femoral neck 1446 (33.4) 2001 (46.2) 885 (20.4)
Trochanter 2014 (46.5) 1646 (38.0) 672 (15.5)
Total hip 2491 (57.5) 1462 (33.7) 379 (8.7)
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higher body mass index (BMI), regular intake of dairy 
products and regular physical activity in the previous 
year and hormone therapy played a protective role 
against fractures (Table 4). After adjustments, ethnic 
background, family history of hip fracture and concomi-
tant medications and diseases were not signifi cantly 
associated with low bone mass.
In the fi nal logistic regression model for low-trauma 
fracture, the main clinical risk factors were menopause, 
advanced age and family history of hip fracture. Regular 
physical activity in the previous year was the only 
factor with a signifi cant association to lower risk of 
fracture (Table 5). The model was adjusted for ethnic 
background, BMI, hormone therapy, current smoking, 
regular intake of dairy products intake and concomitant 
medications and diseases.
DISCUSSION
The present study showed high prevalence of osteo-
porosis among women over 40 years of age, which 
is similar to fi ndings from other studies carried out in 
North America7,30 and Europe.14 Moreover, 11.5% of 
the sample had a past history of fracture due to bone 
frailty, which is consistent with recently published data 
from studies of representative samples of the Brazilian 
population.6, 24
The SAPOS study also revealed that menopause, family 
history of hip fracture, low BMD and advanced age 
were the main risk factors associated to low-trauma 
fracture. In contrast, regular physical activity in the 
previous 12 months was the only factor that played a 
protective role against osteoporotic fracture. Likewise, 
menopause, advanced age and previous fracture were 
significantly associated with greater likelihood of 
having low BMD, whereas higher BMI, hormonal 
replacement therapy and regular physical activity in 
the previous year had a positive effect on BMD, which 
corroborates previous studies.4,31
Being underweight is considered an important risk 
factor for low bone mass and fracture,2,4,28,30 especially 
in populations at high risk for osteoporosis. In the 
present study, however, no harmful effect of being 
underweight was seen on the risk of osteoporotic frac-
ture, although care was taken to investigate anthropo-
metrical data accurately in all the subjects. This fi nding 
may be explained by the greater prevalence of over-
weight and obesity in the present sample, as was also 
recently reported in the BRAZOS study.24 Similarly, 
other studies have been unable to demonstrate the role 
of body weight regarding the risk of hip fracture and 
low BMD.26
The present study found that the majority of women 
had some concomitant diseases, especially related to the 
cardiovascular system. The statistical analysis showed 
no signifi cant association between concomitant diseases 
and low-trauma fracture. Likewise, the use of concomi-
tant medications was not signifi cantly associated with 
greater risk of fracture or low BMD. Although hormone 
replacement therapy has a positive effect on BMD 
and reduces osteoporotic fracture risk, it may increase 
Table 3. Descriptive analysis of bone mass measurements (spine and femur bone mineral density) according to the presence 





N = 497 P
a
Lumbar spine (g/cm2) (SD) 1.018 (0.18) 0.913 (0.15) < 0.001
Femur (g/cm2) (SD)
Neck 0.865 (0.15) 0.775 (0.12) < 0.001
Trochanter 0.743 (0.13) 0.668 (0.13) < 0.001
Total hip 0.925 (0.18) 0.827 (0.14) < 0.001
a Student’s t-test
Table 4. Final multivariate regression model for low bone 
density. Greater São Paulo, Southeastern Brazil, 2004–
2007.
Variable OR (95%CI)
Time since menopause 2.16 (1.49;3.14)
Current smoking 1.45 (1.13;1.85)
Age 1.07 (1.06;1.08)
Regular physical activity in the 
previous year
0.67 (0.57;0.79)
Hormone replacement therapy 0.43 (0.33;0.56)
Body mass index 0.88 (0.86;0.89)
Regular intake of dairy products 0.93 (0.87;0.99)
Table 5. Final logistic regression model for low-trauma fracture. 
Greater São Paulo, Southeastern Brazil, 2004–2007.
Variable OR (95%CI)
Time since menopause 4.16 (1.81;9.56)
Family history of hip fracture 3.59 (2.88;4.47)
Age 1.05 (1.04;1.06)
Regular physical activity in the 
previous year
0.79 (0.63;0.99)
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the risk of cardiovascular events in older women, as 
suggested by the Women’s Health Initiative.27 Regular 
use of thiazide diuretics was considerably prevalent in 
the present sample (29.7%), but was not signifi cantly 
associated to a greater risk of fracture or low BMD, 
as has been reported elsewhere.9 Moreover, although 
used by 4% of the participants, long-term corticosteroid 
therapy was also not signifi cantly associated with low 
bone mass or fractures.
Although more than 30% of the sample had osteopo-
rosis and half had a history of low-trauma fracture, 
only a small subsample was taking medications with 
benefi cial action on bone tissue (10% were receiving 
hormone replacement therapy, 8% biphosphonates 
and 14% calcium supplements, even with low dietary 
intake of calcium). The lack of a diagnosis following 
a fracture event is a major problem in many countries, 
including Brazil.10,23,24 It is highly concerning since 
osteoporotic fracture, especially hip fracture, is associ-
ated to higher mortality rate (23.2%) and prevalence of 
disability (30%).10 Furthermore, it should be stressed 
that the current treatment of osteoporosis can reduce the 
risk of vertebral (50% to 65%) as well as non-vertebral 
fractures (25% to 40%). Therefore, it is unacceptable 
that individuals with a previous event and those at 
a high risk of fracture be deprived of safe, effective 
and cost-efficient treatment for the prevention of 
bone loss and further events.23
The present study has limitations that should be 
addressed. One of them is failure to assess other extra-
skeletal conditions directly related to fractures, such as 
falls, visual and hearing impairment, gait velocity and 
balance. Furthermore, biochemical markers of bone 
remodeling were not measured, and radiographies 
of the thoracic and lumbar spines were not taken to 
detect fractures with little or no symptoms. Thus, the 
prevalence of fractures could be higher than that found 
in the present study.
The results of the present study indicate that the preva-
lence of clinical risk factors for low BMD and fracture 
are similar to those reported in previous studies in 
Caucasian populations. Furthermore, spine and femur 
BMD is also similar to that from two large international 
cohorts: the European Vertebral Osteoporosis Study 
(EVOS)18 and the Latin America Vertebral Osteoporosis 
Study (LAVOS).6 However, the prevalence of fracture 
found in the present study is lower than that reported 
in populations in the United States, Europe and Asia 
using the FRAXTM assessment tool.13 The impact and 
importance of clinical risk factors as well as their inter-
actions, particularly with gender, age, BMD and type of 
fracture, have a crucial epidemiological importance to 
our understanding of these population differences and 
to explain the different fracture risks between popula-
tions that share similar clinical risk factors and BMD. 
Besides, longitudinal and prospective studies should be 
carried out and the FRAXTM tool should be validated 
for use in Brazil.25
Due to its high prevalence and association with 
mortality and disability, osteoporosis and its main 
consequence – fracture due to bone frailty – should 
be considered public health problems in Brazil. The 
implementation of educational actions is extremely 
important to prevent high prevalence of osteopo-
rosis related to aging, such as quit smoking, alcohol 
consumption abuse and promotion of regular physical 
activities and intake of dairy products. The results of the 
present study should be into taken consideration while 
formulating public health policies for prevention and 
early treatment strategies for this disease and resource 
allocation, thereby minimizing the direct and indirect 
costs associated with osteoporotic fractures.
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